Citations (54)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (10)
Xiaojie Su, Ting Lei, Haichuan Yu, Lu Zhang, Zhouzhou Feng, Tiankui Shuai, Hong Guo & Jian Liu. (2023) NT-proBNP in Different Patient Groups of COPD: A Systematic Review and Meta-Analysis. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 811-825.
Read now
Read now
Kostantinos Bartziokas, Anastasia Papaporfyriou, Georgios Hillas, Andriana I. Papaioannou & Stelios Loukides. (2023) Global initiative for chronic obstructive lung disease (GOLD) recommendations: strengths and concerns for future needs. Postgraduate Medicine 135:4, pages 327-333.
Read now
Read now
Ming Hu, Pan Ding, Jinfang Ma, Nan Yang, Jinping Zheng & Naitong Zhou. (2022) Cost-Effectiveness Analysis of the TCM “Yupingfeng Granules” in the Treatment of Acute Exacerbations of COPD Based on a Randomized Clinical Trial. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2369-2379.
Read now
Read now
Hong Zhang, Dandan Hu, Yikai Xu, Lixia Wu & Liming Lou. (2022) Effect of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials. Annals of Medicine 54:1, pages 262-273.
Read now
Read now
Dave Singh, Steve Holmes, Claire Adams, Mona Bafadhel & John R Hurst. (2021) Overcoming Therapeutic Inertia to Reduce the Risk of COPD Exacerbations: Four Action Points for Healthcare Professionals. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3009-3016.
Read now
Read now
Kristian Brat, Michal Svoboda, Jaromir Zatloukal, Marek Plutinsky, Eva Volakova, Patrice Popelkova, Barbora Novotna, Tomas Dvorak & Vladimir Koblizek. (2021) The Relation Between Clinical Phenotypes, GOLD Groups/Stages and Mortality in COPD Patients – A Prospective Multicenter Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 1171-1182.
Read now
Read now
Norihiko Tsuboi, Kaoru Tsuboi, Nobuyuki Nosaka, Nao Nishimura & Satoshi Nakagawa. (2021) The Ventilatory Strategy to Minimize Expiratory Flow Rate in Ventilated Patients with Chronic Obstructive Pulmonary Disease. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 301-304.
Read now
Read now
G. Hillas, A. Papaporfyriou, K. Dimakou & A. I. Papaioannou. (2020) Pharmacological treatment of stable COPD: need for a simplified approach. Postgraduate Medicine 132:2, pages 126-131.
Read now
Read now
Qing Li, Pierre Larivée, Josiane Courteau, Simon Couillard, Thomas G Poder, Nathalie Carrier, Maryse Bélanger & Alain Vanasse. (2019) Greater eosinophil counts at first COPD hospitalization are associated with more readmissions and fewer deaths. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 331-341.
Read now
Read now
Luqi Dai, Junyun He, Jun Chen, Tao Wang, Lian Liu, Yongchun Shen, Lei Chen & Fuqiang Wen. (2018) The association of elevated circulating endocan levels with lung function decline in COPD patients. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3699-3706.
Read now
Read now
Articles from other publishers (44)
Konstantinos Bartziokas, Evgenia Papathanasiou, Andriana I. Papaioannou, Ilias Papanikolaou, Emmanouil Antonakis, Ioanna Makou, Georgios Hillas, Theodoros Karampitsakos, Ourania Papaioannou, Katerina Dimakou, Vasiliki Apollonatou, Galateia Verykokou, Spyros Papiris, Petros Bakakos, Stelios Loukides & Konstantinos Kostikas. (2023) Eosinopenia as a Prognostic Biomarker for Noninvasive Ventilation Use in COPD Exacerbations. Journal of Personalized Medicine 13:4, pages 686.
Crossref
Crossref
Xiao Wu, Run-Feng Li, Zheng-Shi Lin, Chuang Xiao, Bin Liu, Kai-Lin Mai, Hong-Xia Zhou, De-You Zeng, Sha Cheng, Yun-Ceng Weng, Jin Zhao, Rui-Feng Chen, Hai-Ming Jiang, Li-Ping Chen, Ling-Zhu Deng, Pei-Fang Xie, Wei-Min Yang, Xue-Shan Xia & Zi-Feng Yang. (2023) Coinfection with influenza virus and non-typeable Haemophilus influenzae aggregates inflammatory lung injury and alters gut microbiota in COPD mice. Frontiers in Microbiology 14.
Crossref
Crossref
Xuanna Zhao, Ruoxin Su, Rongwei Hu, Yujuan Chen, Xiaoyong Xu, Yalian Yuan, Jinhong Zhang, Wenchao Zhang, Yu Yang, Min Chen, Dongming Li, Bin Wu, Dan Huang & Dong Wu. (2023) Sarcopenia index as a predictor of clinical outcomes among older adult patients with acute exacerbation of chronic obstructive pulmonary disease: a cross-sectional study. BMC Geriatrics 23:1.
Crossref
Crossref
Yide Wang, Zheng Li & Fengsen Li. (2023) Impact of Previous Pulmonary Tuberculosis on Chronic Obstructive Pulmonary
Disease: Baseline Results from a Prospective Cohort Study. Combinatorial Chemistry & High Throughput Screening 26:1, pages 93-102.
Crossref
Crossref
V. D. Fedotov, A. C. Khlystov, T. V. Blinova, L. A. Strakhova, N. A. Lavrenyuk & I. S. Dobrotina. (2022) Hyaluronic acid as a predictor of exacerbation of occupational chronic obstructive pulmonary disease. PULMONOLOGIYA 32:6, pages 862-868.
Crossref
Crossref
Amanda Barrell. (2022) Current Evidence on Tobacco Harm Reduction in Pneumology: Interviews with Two Key Opinion Leaders. European Medical Journal, pages 28-34.
Crossref
Crossref
Ching-Hsiung Lin, Yi-Rong Li, Pei Ru Lin, Bing-Yen Wang, Sheng-Hao Lin, Kuo-Yang Huang & Chew-Teng Kor. (2022) Blood monocyte levels predict the risk of acute exacerbations of chronic obstructive pulmonary disease: a retrospective case–control study. Scientific Reports 12:1.
Crossref
Crossref
Andrea Bianco, Stefano Conte, Domenica Francesca Mariniello, Valentino Allocca, Maria Gabriella Matera, Vito D’Agnano, Luigi Lanata, Mario Cazzola & Fabio Perrotta. (2022) Mucolytic and Antioxidant Properties of Carbocysteine as a Strategy in COVID-19 Therapy. Life 12:11, pages 1824.
Crossref
Crossref
Buğra İlhan, Göksu Bozdereli Berikol & Halil Doğan. (2022) The predictive value of modified risk scores in patients with acute exacerbation of COPD: a retrospective cohort study. Internal and Emergency Medicine 17:7, pages 2119-2127.
Crossref
Crossref
Zhixiang Chen, Lei Zha, Xiao Ma, Jing Xu, Dandan Huang, Wenlong Wu, Long Chen, Feng Yang, Weiling Liao & Wenhua Wang. (2022) Serum Creatinine/Cystatin C Ratio as a Predictor of In-hospital Mortality in Patients Hospitalized with Acute Exacerbation of Chronic Obstructive Pulmonary Disease. Lung 200:5, pages 609-617.
Crossref
Crossref
J. Moita, U. Brito, C. Rodrigues, L. Ferreira, J.R. Vieira, A. Catarino, A. Morais, V. Hespanhol & C.R. Cordeiro. (2022) Chronic obstructive pulmonary disease exacerbations' management in Portuguese hospitals – EvaluateCOPDpt, a multicentre, observational, prospective study. Pulmonology.
Crossref
Crossref
Changhong Zhang, Jianhua Liu, Liang Cao, Gaixia Feng, Zhihua Zhang, Mengmeng Ji & Yaping Zhang. (2022) Deep Learning-Based Computed Tomography Features in Evaluating Early Screening and Risk Factors for Chronic Obstructive Pulmonary Disease. Contrast Media & Molecular Imaging 2022, pages 1-9.
Crossref
Crossref
Yuan Dong & Qingling Li. (2022) Compound Ipratropium Bromide plus Budesonide Inhalation in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease and Its Effect on Heparin-Binding Protein. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-6.
Crossref
Crossref
Laura Taddei, Lucio Malvisi, David S. Hui, Ludovic Malvaux, Ronnie Z. Samoro, Sang Haak Lee, Yiu Cheong Yeung, Yu-Chih Liu & Ashwani Kumar Arora. (2022) Airway pathogens detected in stable and exacerbated COPD in patients in Asia-Pacific. ERJ Open Research 8:3, pages 00057-2022.
Crossref
Crossref
Caroline Hedsund, Philip Mørkeberg Nilsson, Nils Hoyer, Daniel Bech Rasmussen, Claire Præst Holm, Tine Peick Sonne, Jens-Ulrik Stæhr Jensen & Jon Torgny Wilcke. (2022) High-pressure NIV for acute hypercapnic respiratory failure in COPD: improved survival in a retrospective cohort study. BMJ Open Respiratory Research 9:1, pages e001260.
Crossref
Crossref
Kurt Brassington, Stanley M.H. Chan, Simone N. De Luca, Aleksandar Dobric, Suleman A. Almerdasi, Kevin Mou, Huei Jiunn Seow, Osezua Oseghale, Steven Bozinovski, Stavros Selemidis & Ross Vlahos. (2022) Ebselen abolishes vascular dysfunction in influenza A virus-induced exacerbations of cigarette smoke-induced lung inflammation in mice. Clinical Science 136:8, pages 537-555.
Crossref
Crossref
Vishnu Jeganathan, Simon Knight, Matthew Bricknell, Anna Ridgers, Raymond Wong, Danny J. Brazzale, Warren R. Ruehland, Muhammad Aziz Rahman, Tracy L. Leong & Christine F. McDonald. (2022) Impact of smoking status and chronic obstructive pulmonary disease on pulmonary complications post lung cancer surgery. PLOS ONE 17:3, pages e0266052.
Crossref
Crossref
Ying-Yi Chen, Tsai-Chung Li, Chia-Ing Li, Shih-Pin Lin & Pin-Kuei Fu. (2022) Statins Associated with Better Long-Term Outcomes in Aged Hospitalized Patients with COPD: A Real-World Experience from Pay-for-Performance Program. Journal of Personalized Medicine 12:2, pages 299.
Crossref
Crossref
A. Popa, N. Caproș, T. Dumitras, O. Corlateanu, M. Dogot, I. Smolenschi, I. Sirbu & M. Dumitras. 2022. 5th International Conference on Nanotechnologies and Biomedical Engineering. 5th International Conference on Nanotechnologies and Biomedical Engineering
743
749
.
Wei Gao, Lianjun Gao, Feng Yang & Zongjun Li. (2021) Circulating JNK pathway‐associated phosphatase: A novel biomarker correlates with Th17 cells, acute exacerbation risk, and severity in chronic obstructive pulmonary disease patients. Journal of Clinical Laboratory Analysis 36:1.
Crossref
Crossref
Hanna Sandelowsky, Ulla Møller Weinreich, Bernt B. Aarli, Josefin Sundh, Kristian Høines, Georgios Stratelis, Anders Løkke, Christer Janson, Christian Jensen & Kjell Larsson. (2021) COPD – do the right thing. BMC Family Practice 22:1.
Crossref
Crossref
Xueyi Deng, Fuqin Kang, Xueyin Chen, Jiaqi Lai, Xuanchen Guan, Xinfeng Guo & Shaonan Liu. (2021) Comparative Effectiveness and Safety of Seven Qi-Tonifying Chinese Medicine Injections for AECOPD Patients: A Systematic Review and Network Meta-Analysis. Evidence-Based Complementary and Alternative Medicine 2021, pages 1-15.
Crossref
Crossref
Bianca Beghé, Stefania Cerri, Leonardo M. Fabbri & Alessandro Marchioni. (2021) COPD, Pulmonary Fibrosis and ILAs in Aging Smokers: The Paradox of Striking Different Responses to the Major Risk Factors. International Journal of Molecular Sciences 22:17, pages 9292.
Crossref
Crossref
Christina Marisa Bergsøe, Pradeesh Sivapalan, Mohamad Isam Saeed, Josefin Eklöf, Zaigham Saghir, Rikke Sørensen, Tor Biering-Sørensen & Jens-Ulrik Stæhr Jensen. (2021) Risk of Chronic Obstructive Pulmonary Disease Exacerbation in Patients Who Use Methotrexate—A Nationwide Study of 58,580 Outpatients. Biomedicines 9:6, pages 604.
Crossref
Crossref
Konstantinos Gourgoulianis, Alessandro Ruggieri, Alessandra del Vecchio, Fabrizio Calisti, Alessandro Comandini, Giovanna Esposito, Giorgio Di Loreto & Nikolaos Tzanakis. (2021) Prulifloxacin Effectiveness in Moderate-to-Severe Acute Exacerbations of Chronic Bronchitis: Α Noninterventional, Multicentre, Prospective Study in Real-Life Clinical Practice—The “AIOLOS” Study. Canadian Respiratory Journal 2021, pages 1-11.
Crossref
Crossref
Ernesto Crisafulli, Alessandra Manco, Mónica Guerrero, Adrian Ceccato, Arturo Huerta, Albert Gabarrús, Domenico Girelli, Néstor Soler & Antoni Torres. (2020) Age is a determinant of short-term mortality in patients hospitalized for an acute exacerbation of COPD. Internal and Emergency Medicine 16:2, pages 401-408.
Crossref
Crossref
Wenzhe Teng, Hu Chen, Siyao Shi, Yin Wang & Kangyao Cheng. (2021) Effect of bilevel continuous positive airway pressure for patients with type II respiratory failure due to acute exacerbation of COPD. Medicine 100:2, pages e24016.
Crossref
Crossref
Mohamed E. A. Abdelrahim, Haitham Saeed, Hadeer S. Harb & Yasmin M. MadneyMohamed E. A. Abdelrahim, Haitham Saeed, Hadeer S. Harb & Yasmin M. Madney. 2021. Essentials of Aerosol Therapy in Critically ill Patients. Essentials of Aerosol Therapy in Critically ill Patients
1
25
.
Stefan-Marian Frent. 2020. Update in Respiratory Diseases. Update in Respiratory Diseases.
Cristóbal Esteban, Inmaculada Arostegui, Amaia Aramburu, Javier Moraza, Josu Najera-Zuloaga, Myriam Aburto, Susana Aizpiri, Leyre Chasco & José M. Quintana. (2020) Predictive factors over time of health-related quality of life in COPD patients. Respiratory Research 21:1.
Crossref
Crossref
Hiroki Tashiro, Yuki Kurihara, Koichiro Takahashi, Hironori Sadamatsu, Tetsuro Haraguchi, Ryo Tajiri, Ayako Takamori, Shinya Kimura & Naoko Sueoka-Aragane. (2020) Clinical features of Japanese patients with exacerbations of chronic obstructive pulmonary disease. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Rajendra KC, Kelvin W. C. Leong, Belinda McEwan, Julia Lachowicz, Nicholas M. Harkness, Steve Petrovski, Gunasegaran Karupiah & Ronan F. O’Toole. (2020) Draft Genome Sequence of an Isolate of Nontypeable Haemophilus influenzae from an Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Tasmania. Microbiology Resource Announcements 9:19.
Crossref
Crossref
Thotsaporn Morasert, Methus Jantarapootirat, Phichayut Phinyo & Jayanton Patumanond. (2020) Prognostic indicators for in-hospital mortality in COPD with acute exacerbation in Thailand: a retrospective cohort study. BMJ Open Respiratory Research 7:1, pages e000488.
Crossref
Crossref
Theodoros Karampitsakos, Katerina Dimakou, Ourania Papaioannou, Serafeim Chrysikos, Maria Kaponi, Demosthenes Bouros, Argyrios Tzouvelekis & Georgios Hillas. (2020) The role of increased red cell distribution width as a negative prognostic marker in patients with COPD. Pulmonary Pharmacology & Therapeutics 60, pages 101877.
Crossref
Crossref
Tanja Effing & Anke Lenferink. 2020. Enhancing Patient Engagement in Pulmonary Healthcare. Enhancing Patient Engagement in Pulmonary Healthcare
205
230
.
Yamely Mendez, Francisco E. Ochoa-Martinez & Tatiana Ambrosii. (2019) Chronic Obstructive Pulmonary Disease and Respiratory Acidosis in the Intensive Care Unit. Current Respiratory Medicine Reviews 15:2, pages 79-89.
Crossref
Crossref
Dimitrios Toumpanakis, Vyronia Vassilakopoulou, Eleftheria Mizi, Athanasia Chatzianastasiou, Konstantinos Loverdos, Ioanna Vraila, Fotis Perlikos, Dionysios Tsoukalas, Charoula-Eleni Giannakopoulou, Adamantia Sotiriou, Maria Dettoraki, Vassiliki Karavana & Theodoros Vassilakopoulos. (2018) p38 Inhibition Ameliorates Inspiratory Resistive Breathing-Induced Pulmonary Inflammation. Inflammation 41:5, pages 1873-1887.
Crossref
Crossref
Antonio Anzueto & Marc Miravitlles. (2018) Chronic Obstructive Pulmonary Disease Exacerbations: A Need for Action. The American Journal of Medicine 131:9, pages 15-22.
Crossref
Crossref
David Mayhew, Nathalie Devos, Christophe Lambert, James R Brown, Stuart C Clarke, Viktoriya L Kim, Michal Magid-Slav, Bruce E Miller, Kristoffer K Ostridge, Ruchi Patel, Ganesh Sathe, Daniel F Simola, Karl J Staples, Ruby Sung, Ruth Tal-Singer, Andrew C Tuck, Stephanie Van Horn, Vincent Weynants, Nicholas P Williams, Jeanne-Marie Devaster & Tom M A Wilkinson. (2018) Longitudinal profiling of the lung microbiome in the AERIS study demonstrates repeatability of bacterial and eosinophilic COPD exacerbations. Thorax 73:5, pages 422-430.
Crossref
Crossref
Pauline V. van Hirtum, Roy T.M. Sprooten, Jan A. van Noord, Monique van Vliet & Martijn D. de Kruif. (2018) Long term survival after admission for COPD exacerbation: A comparison with the general population. Respiratory Medicine 137, pages 77-82.
Crossref
Crossref
Deog Kyeom KimJungsil LeeJu-Hee ParkKwang Ha Yoo. (2018) What Can We Apply to Manage Acute Exacerbation of Chronic Obstructive Pulmonary Disease with Acute Respiratory Failure?. Tuberculosis and Respiratory Diseases 81:2, pages 99.
Crossref
Crossref
Vanessa M. McDonald, Mary Roberts & Kerry Inder. 2018. Textbook of Pulmonary Rehabilitation. Textbook of Pulmonary Rehabilitation
183
194
.
Vicky Thomas, Eran Gefen, Gokul Gopalan, Rafael Mares, Rosie McDonald, Simon Wan Yau Ming & David B. Price. (2017) Ipratropium/Salbutamol Comparator Versus Originator for Chronic Obstructive Pulmonary Disease Exacerbations: USA Observational Cohort Study Using the Clinformatics™ Health Claims Database. Pulmonary Therapy 3:1, pages 187-205.
Crossref
Crossref
Tomasz Dębowski. (2017) Minimalna różnica istotna klinicznie (MCID) dla zmniejszenia częstości zaostrzeń przewlekłej obturacyjnej choroby płuc – czyli, która terapia jest w rzeczywistości odczuwana przez chorego. Alergologia Polska - Polish Journal of Allergology 4:1, pages 32-38.
Crossref
Crossref